27 patents currently held
11 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
3 more records may belong here and await a decision; they are not counted.
The next term ends in Dec 2028. from the record
Of the 11 now held by other companies, 11 name Apollo Endosurgery US Inc. as their current owner. Each row says so.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
7
Ending by 2030
Dec 2028
Next term end
27
Patent families
When these terms end
Held patents by the year their term ends
notable patents
all others
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Jan 2030 · High confidence
Also notable
Ends May 2032 · High confidence
Also notable
Ends Feb 2033 · High confidence
Watch
US D747,979
The most cited patent in this portfolio, cited by 62 later US patents, top 10% of design patents granted in 2016 in our data. Protection runs to 2030.
Watch
US D786,705
Granted 2017. Computed term ends 2032.
Watch
US D809,940
The newest of the three, granted 2018. It anchors the portfolio to 2033, later than anything else here.
Formerly held, still cited
Notable
Ends Jan 2032 · High confidence
Cited by 48 later US patents, top 10% of utility patents granted in 2015 in our data, and renewed at every maintenance window due so far. Protection runs to 2032.
now held by Apollo Endosurgery US, Inc.
Also notable
Ends Jul 2028 · High confidence
The most cited patent in this portfolio, cited by 77 later US patents, top 10% of utility patents granted in 2012 in our data. Protection runs to 2028.
now held by Apollo Endosurgery US, Inc.
Also notable
Ends Jun 2032 · High confidence
Cited by 22 later US patents, top 25% of utility patents granted in 2015 in our data, and renewed at every maintenance window due so far. Protection runs to 2032.
now held by Apollo Endosurgery US, Inc.
Fee deadlines
No maintenance fee falls due on this company's record before Nov 10, 2027.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
What they patent
The 2 largest of its 27 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Watch (2016) | 1 in force | to Feb 2033 |
| Watch (2015) | 1 in force | to May 2032 |
Patents held now
Soonest term end first.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US D719,467 | Wrist Watch In force · High confidence | In force | High confidence | |
| US D738,854 | Speaker In force · High confidence | In force | High confidence | |
| US D746,157 | Watch In force · High confidence | In force | High confidence | |
| US D747,978 | Watch In force · High confidence | In force | High confidence | |
| US D747,979 | Watch In force · High confidence | In force | High confidence | |
| US D748,995 | Watch In force · High confidence | In force | High confidence | |
| US D749,431 | Watch In force · High confidence | In force | High confidence | |
| US D782,335 | Watch In force · High confidence | In force | High confidence | |
| US D782,336 | Watch In force · High confidence | In force | High confidence | |
| US D782,337 | Watch In force · High confidence | In force | High confidence |
Also on record, not counted in the 27: 11 patents in force now held by others · 14 patents ended · 12 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.